Margrit Carlson is an Infectious Disease physician affiliated with UCLA Health. OpenAlex indexes 19 publications with 728 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingMedicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
89.5%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor22.1%Descovy50%Triumeq32%Abacavir-Lamivudine17%Part D<11 patientsProtease Inhibitor21.5%Prezista38%Ritonavir35%Prezcobix20%Symtuza8%Part D<11 patients+ 4 more classes in this area
Cardiovascular
4.4%Statin4.4%Rosuvastatin Calcium52%Atorvastatin Calcium48%Part D<11 patientsGenitourinary & hormones
2.3%Androgen2.3%Testosterone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1998–2009 per NIH RePORTER. The latest:
- A PHASE II STUDY TO EVALUATE THE IMMUNOGENICITY AND SAFETY OF QUADRIVALENT: HIV
University of California Los Angeles
FY2009$20,558M01RR000865 - A PHASE III, RANDOMIZED, OPEN-LABEL COMPARISON OF LOPINAVIR/RITONAVIR PLUS EF
University of California Los Angeles
FY2007$7,746M01RR000865 - A PHASE III, RANDOMIZED, OPEN-LABEL COMPARISON OF LOPINAVIR/RITONAVIR PLUS EF
University of California Los Angeles
FY2006$46,886M01RR000865
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Joel Kopple, MD
UCLA Health
Lin Chang, MD
UCLA Health
Priscilla Hsue, MD
UCLA Health
Sahib Khalsa, MD
UCLA Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”